The Master's in Biological Therapeutics is a full-time, second-cycle program focused on the design, development, and production of biological medicines. Conducted in English, this program offers a comprehensive blend of theoretical knowledge and practical laboratory skills. It delves into molecular mechanisms, pharmaceutical biophysics, and biotechnological processes essential for creating innovative treatments like nucleic acid-based drugs and therapeutic proteins. Students will also learn about preclinical studies, drug delivery methods, and the ethical considerations involved in research. This program is part of the "Integrated Teaching & Learning Development Programme – ZIP 2.0," which provides additional opportunities for professional development. These include workshops, international trips, collaboration with researchers abroad, financial support for student research, tutoring, and a mentoring program to prepare students for the job market. The curriculum emphasizes critical analysis of scientific literature, effective communication, and the application of bioinformatics tools for drug design and improvement. Graduates will be well-prepared for careers in the innovative biotechnology and biopharmaceutical sectors, working in research and development, production, and quality control of biological and biosimilar drugs. The program's structure, including block teaching for complex experiments, aims to equip students with the practical expertise needed to excel in the modern pharmaceutical industry.
The curriculum integrates knowledge from exact sciences, natural sciences, and medicine, preparing specialists for modern pharmacy and biotechnology. It features block teaching to facilitate complex, multi-stage experiments and maximize laboratory time.
Graduates of the Biological Therapeutics program are prepared to work in the innovative biotechnology and biopharmaceutical sectors. The program emphasizes practical expertise in designing, synthesizing, purifying, and verifying therapeutic biological drugs.
Admission is based on an interview conducted in English. Candidates need to demonstrate subject knowledge, reasoning skills, communication abilities, and logical coherence. An optional Research Experience Letter (REL) can award up to 10 additional points. Candidates with foreign diplomas are assessed under the same rules as candidates with Polish diplomas.
Tuition fees are subject to change and are typically updated for each academic year. The provided fee information pertains to previous academic years.
Not specified
Admission requires a Bachelor's, Master's, or Engineering degree (or equivalent). Candidates are assessed through an interview in English, which evaluates subject knowledge, reasoning, communication, and logical coherence. Optional research experience can provide additional points.
Tuition fee information for the 2026/2027 academic year is not yet available. Fees are subject to change and are typically updated annually; please refer to the University of Warsaw's fee schedule for the most current information.
The Master's in Biological Therapeutics is a full-time, second-cycle program. The curriculum is structured over two years, with classes beginning in October 2026.
The Biological Therapeutics Master's program is conducted entirely in English, and the admission interview is also held in English.
Applications are submitted through the University of Warsaw's Online Candidate Recruitment System (IRK). The process includes online registration, uploading required documents, paying an application fee, and participating in an interview.
Online registration for the program opens on June 9, 2026, and closes on July 9, 2026. Interviews will take place in mid-July 2026, with results announced in late July 2026.